Published in Nat Rev Urol on August 12, 2014
Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Int J Clin Exp Pathol (2015) 0.95
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC Med (2014) 0.92
A river model to map convergent cancer evolution and guide therapy in RCC. Nat Rev Urol (2015) 0.91
The PI3K/AKT Pathway and Renal Cell Carcinoma. J Genet Genomics (2015) 0.90
Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma. Oncotarget (2017) 0.81
Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinoma. Int J Mol Sci (2015) 0.79
Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential. Nitric Oxide (2015) 0.77
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Sci Rep (2016) 0.77
Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma. Cancer Res (2016) 0.76
PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness. Sci Rep (2017) 0.75
Apigenin inhibits renal cell carcinoma cell proliferation. Oncotarget (2017) 0.75
Transarterial embolization of renal tumors improves surgical outcomes: A case series. Int J Surg Case Rep (2015) 0.75
Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now? J Kidney Cancer VHL (2014) 0.75
Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia. BMC Cancer (2016) 0.75
Paediatrics: Towards evidence-based management of paediatric RCC. Nat Rev Urol (2015) 0.75
GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression. Oncotarget (2016) 0.75
Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma. Exp Ther Med (2017) 0.75
RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25. Cancer Sci (2017) 0.75
Lower mean platelet volume predicts poor prognosis in renal cell carcinoma. Sci Rep (2017) 0.75
GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients. J Cell Mol Med (2017) 0.75
Presurgical neoadjuvant targeted molecular therapy for kidney cancer with concomitant vena cava tumor embolus: A clinical study. Oncol Lett (2017) 0.75